tetraiodothyroacetic acid has been researched along with Colonic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abnous, K; Alibolandi, M; Farzad, SA; Ramezani, M; Rezvani, R; Taghdisi, SM | 1 |
Bennett, JA; Changou, CA; Chen, YR; Chin, YT; Davis, PJ; Fu, E; Ho, Y; Incerpi, S; Li, WS; Lin, CY; Lin, HY; Liu, LF; Mousa, SA; Nana, AW; Pedersen, JZ; Shih, YJ; Whang-Peng, J | 1 |
Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B | 1 |
3 other study(ies) available for tetraiodothyroacetic acid and Colonic Neoplasms
Article | Year |
---|---|
Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Female; HT29 Cells; Humans; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Thyroxine | 2017 |
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HMGA2 Protein; Humans; Mice, Nude; Resveratrol; Thyroxine | 2018 |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colonic Neoplasms; Computational Biology; Drug Therapy, Combination; Female; Humans; Models, Biological; Monte Carlo Method; Nanoparticles; Resveratrol; Stilbenes; Thyroxine | 2011 |